학술논문
An Updated Safety and Efficacy Analysis of Venetoclax Plus Daratumumab and Dexamethasone in an Expansion Cohort of a Phase 1/2 Study of Patients with t(11;14) Relapsed/Refractory Multiple Myeloma
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:7261-7263
Subject
Language
ISSN
0006-4971